packageSelpercatinib

selpercatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Selpercatinib is a protein kinase inhibitor used to treat medullary thyroid cancer and non-small-cell lung cancer. It is approved and authorised in the European Union for these cancers.

Summary written by glm-5.3-flash from Wikidata Q96405266 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:selpercatinib
ATC codes:L01EX22
DrugBank:DB15685
PubChem CID:134436906
Wikidata:Q96405266
formula:C29H31N7O3
molar mass:525.613 g/mol (PubChem CID 134436906)
logP:2.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown